Cargando…
Comparison Between Intravenous and Intramuscular Octreotide in the Management of Heyde’s Syndrome
Heyde’s syndrome is defined as a triad of aortic stenosis, anemia due to angiodysplasia-related bleeding, and von Willebrand syndrome type 2A. It is a rare disease and a diagnostic challenge. Treatment modalities include symptomatic management, blood transfusions, aortic valve replacement, and medic...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9239735/ https://www.ncbi.nlm.nih.gov/pubmed/35783893 http://dx.doi.org/10.7759/cureus.25461 |
_version_ | 1784737368879661056 |
---|---|
author | Cheema, Hira I Roark, Russell Hassan, Seemeen Chakrala, Kalyan Tharian, Benjamin Anastasiou, Jiannis |
author_facet | Cheema, Hira I Roark, Russell Hassan, Seemeen Chakrala, Kalyan Tharian, Benjamin Anastasiou, Jiannis |
author_sort | Cheema, Hira I |
collection | PubMed |
description | Heyde’s syndrome is defined as a triad of aortic stenosis, anemia due to angiodysplasia-related bleeding, and von Willebrand syndrome type 2A. It is a rare disease and a diagnostic challenge. Treatment modalities include symptomatic management, blood transfusions, aortic valve replacement, and medications such as octreotide. Here, we report the case of a patient who was resistant to symptomatic management, aortic valve replacement, as well as intravenous octreotide. |
format | Online Article Text |
id | pubmed-9239735 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Cureus |
record_format | MEDLINE/PubMed |
spelling | pubmed-92397352022-07-02 Comparison Between Intravenous and Intramuscular Octreotide in the Management of Heyde’s Syndrome Cheema, Hira I Roark, Russell Hassan, Seemeen Chakrala, Kalyan Tharian, Benjamin Anastasiou, Jiannis Cureus Gastroenterology Heyde’s syndrome is defined as a triad of aortic stenosis, anemia due to angiodysplasia-related bleeding, and von Willebrand syndrome type 2A. It is a rare disease and a diagnostic challenge. Treatment modalities include symptomatic management, blood transfusions, aortic valve replacement, and medications such as octreotide. Here, we report the case of a patient who was resistant to symptomatic management, aortic valve replacement, as well as intravenous octreotide. Cureus 2022-05-29 /pmc/articles/PMC9239735/ /pubmed/35783893 http://dx.doi.org/10.7759/cureus.25461 Text en Copyright © 2022, Cheema et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Gastroenterology Cheema, Hira I Roark, Russell Hassan, Seemeen Chakrala, Kalyan Tharian, Benjamin Anastasiou, Jiannis Comparison Between Intravenous and Intramuscular Octreotide in the Management of Heyde’s Syndrome |
title | Comparison Between Intravenous and Intramuscular Octreotide in the Management of Heyde’s Syndrome |
title_full | Comparison Between Intravenous and Intramuscular Octreotide in the Management of Heyde’s Syndrome |
title_fullStr | Comparison Between Intravenous and Intramuscular Octreotide in the Management of Heyde’s Syndrome |
title_full_unstemmed | Comparison Between Intravenous and Intramuscular Octreotide in the Management of Heyde’s Syndrome |
title_short | Comparison Between Intravenous and Intramuscular Octreotide in the Management of Heyde’s Syndrome |
title_sort | comparison between intravenous and intramuscular octreotide in the management of heyde’s syndrome |
topic | Gastroenterology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9239735/ https://www.ncbi.nlm.nih.gov/pubmed/35783893 http://dx.doi.org/10.7759/cureus.25461 |
work_keys_str_mv | AT cheemahirai comparisonbetweenintravenousandintramuscularoctreotideinthemanagementofheydessyndrome AT roarkrussell comparisonbetweenintravenousandintramuscularoctreotideinthemanagementofheydessyndrome AT hassanseemeen comparisonbetweenintravenousandintramuscularoctreotideinthemanagementofheydessyndrome AT chakralakalyan comparisonbetweenintravenousandintramuscularoctreotideinthemanagementofheydessyndrome AT tharianbenjamin comparisonbetweenintravenousandintramuscularoctreotideinthemanagementofheydessyndrome AT anastasioujiannis comparisonbetweenintravenousandintramuscularoctreotideinthemanagementofheydessyndrome |